News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
20,144 Results
Type
Article (1189)
Company Profile (2)
Press Release (18953)
Section
Business (5809)
Career Advice (93)
Deals (1060)
Drug Delivery (9)
Drug Development (2291)
Employer Resources (7)
FDA (961)
Job Trends (478)
News (10257)
Policy (1028)
Tag
Academia (65)
Accelerated approval (2)
Allergies (2)
Alliances (1060)
ALS (3)
Alzheimer's disease (26)
Antibody-drug conjugate (ADC) (7)
Approvals (971)
Artificial intelligence (17)
Autoimmune disease (1)
Automation (2)
Bankruptcy (11)
Best Places to Work (428)
Biotechnology (2)
Bladder cancer (2)
Brain cancer (2)
Breast cancer (7)
Cancer (129)
Cardiovascular disease (28)
Career advice (82)
CAR-T (4)
CDC (1)
Cell therapy (10)
Cervical cancer (2)
Clinical research (2174)
Collaboration (28)
Compensation (23)
COVID-19 (50)
CRISPR (2)
C-suite (9)
Cystic fibrosis (21)
Data (188)
Depression (10)
Diabetes (17)
Diagnostics (199)
Digital health (4)
Diversity, equity & inclusion (1)
Drug discovery (4)
Drug pricing (19)
Duchenne muscular dystrophy (3)
Earnings (4107)
Editorial (5)
Employer resources (7)
Events (2090)
Executive appointments (4)
FDA (1112)
Frontotemporal dementia (1)
Funding (45)
Gene editing (9)
Generative AI (2)
Gene therapy (15)
GLP-1 (41)
Government (164)
Guidances (39)
Healthcare (563)
HIV (8)
Huntington's disease (1)
Immunology and inflammation (3)
Immuno-oncology (2)
Indications (5)
Infectious disease (53)
Inflammatory bowel disease (8)
Inflation Reduction Act (2)
Intellectual property (5)
Interviews (16)
IPO (593)
IRA (8)
Job creations (76)
Job search strategy (66)
JPM (1)
Layoffs (9)
Leadership (4)
Legal (205)
Liver cancer (3)
Lung cancer (12)
Lymphoma (53)
Machine learning (1)
Management (4)
Manufacturing (24)
MASH (4)
Medical device (1012)
Medtech (1016)
Mergers & acquisitions (492)
Metabolic disorders (37)
Multiple sclerosis (1)
Neurodegenerative disease (4)
Neuropsychiatric disorders (6)
Neuroscience (59)
NextGen: Class of 2026 (220)
Non-profit (73)
Obesity (14)
Opinion (22)
Ovarian cancer (2)
Pain (9)
Pancreatic cancer (1)
Parkinson's disease (9)
Patents (9)
Patient recruitment (17)
Peanut (1)
People (730)
Pharmaceutical (1)
Pharmacy benefit managers (2)
Phase 1 (492)
Phase 2 (801)
Phase 3 (1052)
Pipeline (263)
Policy (20)
Postmarket research (96)
Preclinical (113)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (6)
Rare diseases (34)
Real estate (90)
Recruiting (3)
Regulatory (812)
Reports (4)
Research institute (48)
Resumes & cover letters (12)
RNA editing (1)
RSV (2)
Schizophrenia (6)
Series A (5)
Series B (3)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (3)
Sponsored (3)
Startups (68)
Supply chain (2)
Tariffs (3)
The Weekly (1)
Vaccines (17)
Venture capital (2)
Weight loss (12)
Women's health (1)
Worklife (1)
Date
Last 7 days (15)
Last 30 days (52)
Last 365 days (967)
2026 (61)
2025 (983)
2024 (1185)
2023 (1283)
2022 (1774)
2021 (1631)
2020 (1556)
2019 (1390)
2018 (1184)
2017 (1103)
2016 (973)
2015 (1164)
2014 (844)
2013 (650)
2012 (613)
2011 (710)
2010 (555)
Location
Africa (31)
Alabama (1)
Alaska (1)
Arizona (9)
Asia (1159)
Australia (122)
California (301)
Canada (86)
China (15)
Colorado (23)
Connecticut (4)
Delaware (24)
Europe (2936)
Florida (99)
Georgia (29)
Illinois (27)
India (4)
Indiana (37)
Iowa (1)
Japan (3)
Kansas (28)
Kentucky (3)
Louisiana (2)
Maine (1)
Maryland (27)
Massachusetts (181)
Michigan (13)
Minnesota (9)
Missouri (6)
Montana (4)
Nevada (2)
New Hampshire (3)
New Jersey (63)
New Mexico (1)
New York (71)
North Carolina (99)
Northern California (165)
Ohio (6)
Oregon (3)
Pennsylvania (70)
South America (34)
Southern California (103)
Tennessee (10)
Texas (39)
United States (1208)
Utah (11)
Virginia (1)
Washington D.C. (2)
Washington State (20)
Wisconsin (3)
20,144 Results for "fortuna fix".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sagimet Biosciences and TAPI Announce Global License Agreement for Innovative Forms of Resmetirom API for Sagimet’s Fixed Dose Combination Program
December 17, 2025
·
8 min read
Opinion
Fixing the IRA’s Pill Penalty Is Critical to Supporting Small Molecule Innovation
Price-negotiation provisions that are out of step with reality are discouraging funders and Big Pharma partners from investing in potentially transformative therapies. Fixing some of the unintended consequences of the IRA will clear the way for innovative medicines to reach patients in need.
February 25, 2025
·
6 min read
·
Thomas M. Kaiser
Opinion
Fixing CGT Manufacturing Requires Not Automation, but a Return to Basics
The primary focus in scaling up production should first be the adoption of lean manufacturing principles used in virtually every other industry.
August 5, 2025
·
5 min read
·
Josh Ludwig
Press Releases
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
December 8, 2025
·
16 min read
Press Releases
Atea Pharmaceuticals Presents New Data Supporting the Fixed-Dose Combination of Bemnifosbuvir and Ruzasvir as a Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Liver Meeting® 2025
November 10, 2025
·
11 min read
Press Releases
Daiichi Sankyo Announces the Development of a Fixed-Triple Combination Lipid-Lowering Tablet to Address Persistent Gaps in the Management of Elevated LDL-C
September 1, 2025
·
6 min read
Press Releases
Qlaris Bio Announces Development of Fixed-Dose Combination Therapy with QLS‑111 and Latanoprost for the Treatment of Glaucoma
June 11, 2025
·
3 min read
Cancer
AstraZeneca’s Calquence Aces Phase III CLL Trial, Eyes Fixed-Duration Approval
AstraZeneca is seeking a fixed-duration approval for Calquence, which will allow patients with chronic lymphocytic leukemia to take breaks from the therapy and prevent excessive toxicities and drug resistance.
July 30, 2024
·
2 min read
·
Tristan Manalac
Editorial
Serena Williams Hawks GLP-1s for Ro Even as Pharmas Face Tightening Oversight
The FDA has vowed to fix a pharma ad loophole—but they’re targeting the wrong one.
September 17, 2025
·
3 min read
·
Annalee Armstrong
Tariffs
J&J CEO Duato Urges Tax Fix, Not Tariffs To Drive US Pharma Manufacturing
In the company’s first-quarter earnings call Tuesday, J&J CEO Joaquin Duato said there’s a better way to encourage drug manufacturing in the U.S. than President Donald Trump’s threatened pharma tariffs.
April 15, 2025
·
3 min read
·
Annalee Armstrong
1 of 2,015
Next
